Mid-size biopharma company with pros and cons - Recensione dipendente - Manager presso Regeneron

4,0
16 gen 2022
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

-Science is interesting, company does 100% discovery in-house and takes development through the entire spectrum -Company is mid-size and growing, so not as "corporate" as big pharma but more resources than small biotech -People are approachable and down-to-earth, for the most part; culture is more casual vs buttoned up -While not in NYC proper, HQ is close enough to commute for those interested in more of a city lifestyle vs some other pharma locations. Also feasible for commuters from Connecticut and NJ

Svantaggi

-Lack of infrastructure/process can make getting things done challenging sometimes -Some growing pains with expanding globally. Most products are partnered with global companies for commercialization, which can hinder strategic autonomy and slow decision-making -IMO positions are undertitled and there seems to be a trend of hiring in more senior colleagues rather than advancing current employees' development

Esplora altre recensioni su Regeneron

5,0
13 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

exciting work and you learn a lot

Svantaggi

You work a lot, but the politics is probably the main issue

3,0
22 giu 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good pay and benefits. Flexibility of work hours.

Svantaggi

If you're in the wrong group, it's a struggle to get autonomy even when you ask for more oversight of a group or project because micromanaging is an issue. I feel trapped where I am and growth has been stagnant. They also hold a mistake against you for years. Management afraid to give constructive criticism.

Vedi recensioni per: Utile|Valutazione|Data|Tutto